The positive news on malaria vaccine development announced this week has provided a boost to all of us who are working to develop new vaccines to fight infectious diseases that impact the poorest and most vulnerable communities.
Tuberculosis, vaccine and regulatory experts convened at a scientific symposium to discuss clinical development aspects of TB vaccine research in Bethesda, Maryland, on September 7, 2011. This event marked the second meeting on TB vaccine research of a new bi-annual symposium program co-sponsored by Aeras and the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health.
Greater political will needed to address TB vaccine development and future introduction challenges
A scientific symposium to kick-start discussion on novel areas of TB vaccine research was held in Bethesda, Maryland on March 7, 2011.
At a global gathering on TB vaccine development in Tallinn, Estonia (21-24 September 2010), the world’s top TB vaccine scientists, researchers and advocates met to review progress and challenges in the TB vaccine field and to set a renewed course for future directions in the TB vaccine development.